These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18287179)

  • 1. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
    Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
    Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
    Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
    Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients.
    Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
    Transplant Proc; 2005; 37(6):2491-2. PubMed ID: 16182720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, homocysteine and carotid intima-media thickness.
    Baptista AP; Cacdocar S; Palmeiro H; Faísca M; Carrasqueira H; Morgado E; Sampaio S; Cabrita A; Silva AP; Bernardo I; Gome V; Neves PL
    Rev Port Cardiol; 2008 Jan; 27(1):39-48. PubMed ID: 18447036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease.
    Veringa SJ; Nanayakkara PW; van Ittersum FJ; Vegting IL; van Guldener C; Smulders YM; ter Wee PM; Stehouwer CD
    Clin Nephrol; 2012 Oct; 78(4):263-72. PubMed ID: 22981031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD.
    Zoungas S; Cameron JD; Kerr PG; Wolfe R; Muske C; McNeil JJ; McGrath BP
    Am J Kidney Dis; 2007 Oct; 50(4):622-30. PubMed ID: 17900462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of haemodialysis on early markers of atherosclerosis.
    Kovacic V; Ljutic D; Dodig J; Radic M; Duplancic D
    Nephrology (Carlton); 2008 Dec; 13(6):472-9. PubMed ID: 18518941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.
    Litwin M; Wühl E; Jourdan C; Niemirska A; Schenk JP; Jobs K; Grenda R; Wawer ZT; Rajszys P; Mehls O; Schaefer F
    Nephrol Dial Transplant; 2008 Aug; 23(8):2552-7. PubMed ID: 18344239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-group vitamins, MTHFR C677T polymorphism and carotid intima-media thickness in clinically healthy subjects.
    Liu CS; Chen CH; Chiang HC; Kuo CL; Huang CS; Cheng WL; Wei YH; Chen HW
    Eur J Clin Nutr; 2007 Aug; 61(8):996-1003. PubMed ID: 17228344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
    Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
    J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
    Heinz J; Kropf S; Domröse U; Westphal S; Borucki K; Luley C; Neumann KH; Dierkes J
    Circulation; 2010 Mar; 121(12):1432-8. PubMed ID: 20231532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol.
    Reid JA; Wolsley C; Lau LL; Hannon RJ; Lee B; Young IS; Soong CV
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):464-8. PubMed ID: 16099694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.
    Mann JF; Sheridan P; McQueen MJ; Held C; Arnold JM; Fodor G; Yusuf S; Lonn EM;
    Nephrol Dial Transplant; 2008 Feb; 23(2):645-53. PubMed ID: 18003666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of common carotid artery intima media thickness, intracranial arterial stenosis and post-stroke cognitive impairment.
    Lee YH; Yeh SJ
    Acta Neurol Taiwan; 2007 Dec; 16(4):207-13. PubMed ID: 18220013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism.
    Ishizaka N; Ishizaka Y; Toda E; Koike K; Seki G; Nagai R; Yamakado M
    Hypertens Res; 2007 Nov; 30(11):1035-41. PubMed ID: 18250552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.